Kestra Medical Technologies, Ltd.
KMTSNASDAQHealthcare● Active
$19.40
$-1.05(-5.13%)
Market Cap$1.1B
P/E Ratio—
52W High$30
52W Low$13.25
Kestra Medical Technologies, Ltd. (KMTS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · KMTS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-04 | 2024-04 | 2023-04 | 2021-04 | 2020-04 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $59.81M | $27.81M | $7.63M | $0.00M | $0.00M |
| Cost of Revenue | $35.60M | $27.45M | $18.28M | $0.00M | $0.00M |
| Gross Profit | $24.21M | $0.36M | ($10.65M) | $0.00M | $0.00M |
| Gross Margin %(computed) | 40.47% | 1.30% | -139.59% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $15.65M | $15.49M | $15.76M | $18.81M | $22.80M |
| G&A Expenses | $0.00M | $29.25M | $19.09M | $0.00M | $0.00M |
| Total Operating Expenses | $130.59M | $85.42M | $69.77M | $32.71M | $29.32M |
| Operating Income | ($106.38M) | ($85.06M) | ($80.42M) | ($32.71M) | ($29.32M) |
| Operating Margin %(computed) | -177.85% | -305.83% | — | — | — |
| Interest Income | $3.20M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $7.73M | $6.23M | $5.63M | $1.17M | $0.00M |
| Income Before Tax | ($113.68M) | ($94.10M) | ($84.22M) | ($33.91M) | ($29.32M) |
| Income Tax Expense | $0.14M | $0.02M | $0.01M | $0.19M | $0.15M |
| Net Income | ($113.81M) | ($94.12M) | ($84.24M) | ($34.10M) | ($29.47M) |
| Net Margin %(computed) | -190.28% | -338.39% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-5.13 | $-2.04 | $-1.75 | $-0.69 | $-0.59 |
| Wtd Avg Shares | 49.53M | 49.53M | 49.53M | 49.53M | 49.53M |
| EBITDA | ($97.98M) | ($76.31M) | ($73.74M) | ($32.33M) | ($28.84M) |
| EBITDA Margin %(computed) | -163.80% | -274.34% | -966.44% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Kestra Medical Technologies, Ltd. data
About Kestra Medical Technologies, Ltd. (KMTS) Income Statement
Kestra Medical Technologies, Ltd. (KMTS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, KMTS reported revenue of $0.06B, gross profit of $0.02B (gross margin 40.47%), and net income of ($0.11B) — a net profit margin of -190.28%.
Frequently asked questions
KMTS · 4 questionsKestra Medical Technologies, Ltd. (KMTS) reported revenue of $0.06B for 2025, up 115.1% year-over-year.
KMTS revenueKMTS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08